Spain's Hipra eyes European use of COVID-19 vaccine, competition with Novavax
Elia Torroella, Vice-President and R&D chief of Spanish pharmaceutical company Hipra, reacts during an interview at its headquarters in Amer, near Girona, Spain, December 2, 2021. Picture taken December 2, 2021. REUTERS/Nacho Doce